Open access
Aug 2026
Human thymic Treg-derived extracellular vesicles display a defined proteomic and miRNA signature with donor-variable suppressive activity
ThyTreg-derived EVs are identified as a novel, cell-free platform with potential for immunomodulatory therapies and a defined molecular cargo.
Marta Fernández-Castillo, E. Blázquez-López, Esther Bernaldo-de-Quirós et al.
· Molecular Medicine · 0 citations